{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:40:40Z","timestamp":1774600840286,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,2,1]]},"DOI":"10.1093\/ajhp\/56.3.217","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T02:58:31Z","timestamp":1550890711000},"page":"217-224","source":"Crossref","is-referenced-by-count":24,"title":["Ropinirole: A dopamine agonist for the treatment of Parkinson\u2019s disease"],"prefix":"10.1093","volume":"56","author":[{"given":"Mary D.","family":"Kuzel","sequence":"first","affiliation":[{"name":"Pharmacy Practice, College of Pharmacy, North Dakota State University, and Clinical Pharmacist\/Managed Care, Dakota Clinic, 1702 South University Drive, Fargo, ND 58103"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/56\/3\/217\/28412998\/ajhp0217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T09:58:55Z","timestamp":1555322335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/56\/3\/217\/5150951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/56.3.217","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,2,1]]},"published":{"date-parts":[[1999,2,1]]}}}